Why acne-prone skin can be oily and dry at the same time

Acne-prone skin can be oily and dry at the same time because surface oil and water retention are different functions. Clinical research has observed higher sebum production alongside lower hydration in acne-affected skin, and acne medicines can add dryness or irritation. Gentle cleansing, a suitable moisturiser and review of the treatment routine can help address discomfort while acne control continues.^{1, 2, 7, 8}

Key messages

• Surface shine does not establish that the outer skin is well hydrated.^{1, 2}

• Consider acne-associated changes, medication effects and avoidable skincare irritation together.^{1, 4, 6}

• Assess acne response and comfort separately. Less acne does not make persistent stinging or peeling unimportant.^{7, 10}

• Choose supportive skincare by the complete formulation and the patient’s needs, and agree any prescription adjustments with the treating clinician.^{4, 7, 8}

Why does surface oil not prevent dryness?

Sebum is the oil produced by sebaceous glands and delivered to the surface through the hair-follicle and gland unit. Hydration describes water content in the stratum corneum, the outermost skin layer. These features interact, but an oily surface does not show how effectively that layer retains water.

The stratum corneum contains flattened skin cells surrounded by organised lipids. Ceramides, cholesterol and free fatty acids contribute to this water-retaining barrier. Surface sebum and the lipids between these cells are different: acne-affected skin has been described as having higher sebum output alongside lower total ceramides and other lipid differences.²

Transepidermal water loss (TEWL) measures water moving through the epidermis and out to the environment. Some loss is normal. Under comparable conditions, higher TEWL can indicate reduced water-barrier function. Conductance testing instead provides a hydration-related measurement, while sebum measurements describe oil production.^{1, 2, 4}

Water also helps keep the outer skin flexible and supports the normal shedding of individual cells. Reduced water content can contribute to roughness and scaling. Neither a symptom nor a TEWL value identifies the cause by itself, so interpret findings with the examination, treatment history and exposures.⁴

A useful explanation is: “Your skin can still make oil while its outer layer has difficulty holding enough water.” This validates an oily-but-tight complaint and opens a discussion about what the skin needs.

Can acne itself affect water retention?

Barrier changes may precede treatment. Acne is an inflammatory disease of the hair-follicle and sebaceous-gland unit, and consensus guidance associates acne processes with altered barrier function.²

A physiological study described in a 2013 barrier review compared young men with mild-to-moderate acne with age-matched male controls. The acne group had higher sebum secretion and TEWL, lower hydration-related conductance, and lower total ceramides and free sphingosine. The study comparison below gives the population details.¹

These observations explain how oiliness and reduced hydration can coexist. They do not establish one pattern in every person with acne. Current evidence also leaves uncertainty about how much impairment is inherent to acne, linked to inflammation during flares, or present in apparently unaffected skin. Consider the disease and its treatment together rather than assigning every dry area to one cause.^{1, 4}

How can topical acne treatment contribute to dryness?

Topical retinoids help unclog pores and reduce inflammation. They can also change the way outer skin cells develop and adhere, leading to redness, peeling and flaking. Dryness and irritation often occur in the first few weeks and may improve with an appropriate, tolerated regimen.^{4, 5, 6}

This early adjustment is sometimes called retinisation. Explain the expected course, but assess symptoms that interfere with treatment use rather than dismiss them under that label.^{6, 7}

Benzoyl peroxide reduces acne-associated bacteria and can cause dryness or irritation. Experimental evidence discussed in a barrier review reports increased TEWL after application. Salicylic acid can also dry or irritate skin; the effect depends on the preparation and how it is used.^{3, 4, 7, 8}

The mechanism is not identical for every medicine. Retinoid-associated permeability changes do not appear to depend on reduced intercellular barrier lipids. “Stripping protective oils” is therefore an incomplete explanation for all treatment reactions.¹

Consider the vehicle, meaning the formulation carrying the medicine, as well as the active ingredient. The EuroGuiDerm European acne-treatment guideline identifies vehicle choice as relevant to topical efficacy and tolerability. The amount, frequency, application area and other products used alongside treatment also need review.^{4, 18}

What additional support may be needed with oral isotretinoin?

Oral isotretinoin can cause dryness beyond the facial application sites relevant to topical treatment. Dry skin, chapped lips and dry or irritated eyes are common, so ask about each rather than waiting for the patient to volunteer discomfort.^{2, 9}

Suitable moisturisers or emollients, which soften and smooth dry skin, may be useful on the face and body after washing and when skin feels dry. American Academy of Dermatology (AAD) advice includes petroleum jelly for dry lips indoors and lip balm with sun protection factor (SPF) 30 or higher outdoors.⁹

Troublesome adverse effects belong in the discussion with the prescribing team, which can review supportive care and the treatment plan. The patient should know how to obtain advice rather than rely on general application guidance intended for topical medicines.⁹

Why can acne improve while dryness remains troublesome?

A medicine can improve acne and still cause unwanted surface effects. Benzoyl peroxide, for example, reduces inflammatory and non-inflammatory lesions while dryness, peeling or irritation may also occur. Each outcome deserves direct assessment.¹⁰

At review, ask whether new lesions are reducing and whether discomfort changes how the patient uses treatment. Include stinging, pain, peeling and applications missed because of symptoms. Photographs showing less acne do not establish that the routine is comfortable.

Peeling is not the treatment target, and applying more medication than prescribed does not clear acne faster. A comfortable routine may be easier to maintain, but hydration measurements and lesion counts do not measure adherence. Ask how treatment is actually being used.^{7, 11}

What should supportive skincare do?

Start by asking about the full routine: cleansers, toners, exfoliants, cosmetics and non-prescription acne products. Simplify avoidable irritation while preserving the purpose of the prescribed treatment.

Use gentle, non-abrasive cleansing with fingertips rather than scrubbing tools or washcloths. AAD guidance recommends washing up to twice daily and after sweating. The National Institute for Health and Care Excellence (NICE) acne guideline similarly recommends a non-alkaline synthetic detergent, or syndet, cleanser twice daily.^{12, 17}

Moisturise when skin is dry, even if it looks oily. A tolerated, non-comedogenic formula, intended not to clog pores, can help; fragrance-free options feature in supportive-care recommendations. Applying moisturiser after washing helps retain water. Follow medicine-specific instructions when deciding its timing relative to treatment.^{2, 8}

A single formulation can combine these functions. Ceramides may be included as physiological barrier lipids, but the ingredient list alone does not establish how well a product performs. Match the formula to symptoms, comfort, texture preferences and affordability rather than requiring a separate serum, lipid cream and occlusive layer.^{2, 4}

L’Oréal Dermatological Beauty Pro provides further learning on ceramides and skin-barrier function. This educational resource complements the clinical assessment; it does not establish an outcome for every ceramide-containing product.

Review astringents, abrasive scrubs and unnecessary exfoliating steps when the skin is peeling or stinging. Include broad-spectrum SPF 30 or higher and appropriate shade and clothing, particularly when treatment increases sun sensitivity. For the wider routine, see Day-to-day care for acne.^{12, 13}

What does the clinical evidence show?

Barrier research and adjunctive-skincare trials answer different questions. The comparisons below separate acne-associated measurements from treatment-related dryness and tested moisturiser outcomes.

Scroll horizontally to view the full table.

The evidence supports considering moisturising alongside acne therapy while keeping expectations specific. The tazarotene trial reported early dryness benefit; the ceramide/niacinamide trial did not demonstrate better hydration or water-loss outcomes than its comparison cream. These are useful distinctions when discussing the complete formula rather than attributing an effect to one ingredient.^{14, 15}

Comfort, treatment use and acne outcomes should also remain distinct. A survey cited by the adult-acne consensus associated cleanser and moisturiser use with better adherence, but did not isolate a causal moisturiser effect. Ask about actual use alongside symptoms and acne response.¹⁴

A ceramide-moisturiser overview on LDB Pro summarises expert recommendations for adjunctive skincare. It is a background consensus resource rather than a new controlled trial.

How should treatment and persistent dryness be reviewed?

Review the medicine, strength, vehicle, amount, application area and frequency, together with recent changes. A deliberate prescription combination can address complementary acne mechanisms; it differs from unplanned layering of irritating products.⁶

For retinoids, clinician-guided options may include a smaller amount, less frequent use or applying moisturiser first. Lower benzoyl peroxide concentrations may be better tolerated. Agree a specific plan using the actual medicine’s instructions rather than leaving the patient to experiment.^{7, 10}

There is no universal barrier-reset duration, treatment break or restart schedule. Explain what continues, what changes, when it will be reviewed and whom to contact if symptoms worsen. Nurses and pharmacists can help establish what is being used and involve the prescriber when a prescription adjustment is needed.⁷

Persistent dryness or burning and stinging from products should prompt reassessment. Review onset, distribution, triggers, previous reactions and effects on sleep, washing or medication use. Another skin condition may contribute, so do not simply escalate moisturising indefinitely.¹⁶

Retinoid irritation does not usually mean allergy, while contact allergy is a recognised uncommon adverse effect of benzoyl peroxide. Symptoms alone may not classify the reaction. Involve the isotretinoin prescribing team for troublesome treatment-related effects.^{7, 9, 10}

Close with separate plans for acne control and comfort. The patient should know how success will be judged and how to obtain earlier advice if discomfort makes the regimen difficult to follow.

References

1. Thiboutot D, Del Rosso JQ. Acne Vulgaris and the Epidermal Barrier: Is Acne Vulgaris Associated with Inherent Epidermal Abnormalities that Cause Impairment of Barrier Functions? Do Any Topical Acne Therapies Alter the Structural and/or Functional Integrity of the Epidermal Barrier?. J Clin Aesthet Dermatol. 2013;6(2):18–24. View source ↗
2. Schachner LA, Alexis AF, Andriessen A, et al. Insights into acne and the skin barrier: Optimizing treatment regimens with ceramide-containing skincare. J Cosmet Dermatol. 2023;22(11):2902–2909. doi:10.1111/jocd.15946. View source ↗
3. Baldwin H, Frey C, Hebert A, Lain ET, Schlesinger T. An Algorithm Integrating Acneceuticals into the Management of Acne Vulgaris. J Drugs Dermatol. 2025;24(4):376–380. doi:10.36849/JDD.8887. View source ↗
4. Del Rosso JQ, Kircik L. Skin 101: Understanding the Fundamentals of Skin Barrier Physiology—Why is This Important for Clinicians?. J Clin Aesthet Dermatol. 2025;18(2):7–15. View source ↗
5. American Academy of Dermatology. American Academy of Dermatology issues updated guidelines for the management of acne [Internet]. Accessed 3 November 2026. View source ↗
6. Iyengar L, Welsh B. Acne vulgaris: a clinical update. Aust Prescr. 2026;49:138–144. doi:10.18773/austprescr.2026.029. View source ↗
7. American Academy of Dermatology. Acne: Diagnosis and treatment [Internet]. Accessed 3 November 2026. View source ↗
8. American Academy of Dermatology. Moisturizer: Why you may need it if you have acne [Internet]. Accessed 3 November 2026. View source ↗
9. American Academy of Dermatology. Isotretinoin: The truth about safety, side effects, and skin care [Internet]. Accessed 3 November 2026. View source ↗
10. Nelson M. Acne Management: Guidelines From the American Academy of Dermatology. Am Fam Physician. 2025;112(5):574–576. View source ↗
11. Lynde CW, Andriessen A, Barankin B, et al. Moisturizers and ceramide-containing moisturizers may offer concomitant therapy with benefits. J Clin Aesthet Dermatol. 2014;7(3):18–26. View source ↗
12. American Academy of Dermatology. Acne: Tips for managing [Internet]. Accessed 3 November 2026. View source ↗
13. De Cruz R, Nguyen R, Chen P, et al. From Monotherapy to Adjunctive Therapies: Application of Dermocosmetics in Acne Management Across Australia and New Zealand. Australas J Dermatol. 2025;66(4):189–198. doi:10.1111/ajd.14447. View source ↗
14. Baldwin HE, Ablon G, Callender V, et al. Challenges in Adult Acne and the Role of Skin Care in Managing the Condition. J Drugs Dermatol. 2024;23(8):674–679. doi:10.36849/JDD.8471. View source ↗
15. Tempark T, Shem A, Lueangarun S. Efficacy of ceramides and niacinamide-containing moisturizer versus hydrophilic cream in combination with topical anti-acne treatment in mild to moderate acne vulgaris: A split face, double-blinded, randomized controlled trial. J Cosmet Dermatol. 2024;23(5):1758–1765. doi:10.1111/jocd.16212. View source ↗
16. American Academy of Dermatology. Dermatologists' top tips for relieving dry skin [Internet]. Accessed 3 November 2026. View source ↗
17. National Institute for Health and Care Excellence. Acne vulgaris: management (NG198). Recommendations, section 1.2: skin care advice. Updated 30 April 2026. View recommendations ↗
18. Nast A et al. EuroGuiDerm Guideline for the Treatment of Acne: Update 2025. European Dermatology Forum. Section 2.4, vehicle considerations. View guideline ↗

Evidence note. The 2023 US acne-barrier consensus reported no comparative skincare studies in its literature search and based its skincare recommendations on clinical experience and panel opinion. It received an unrestricted manufacturer educational grant and reported author consultancy fees. This limits the certainty and product specificity of its recommendations; it does not negate the separate clinical studies cited here.²